Relationship between enterotoxigenic Escherichia coli and diarrhea among children in Buenos Aires.
The incidence of enterotoxigenic Escherichia coli (ETEC) has been studied in 85 children with acute diarrhea in patients in the Hospital de Niños Pedro de Elizalde, Buenos Aires, and in 38 healthy children. All of them were up to four years old and none had received antibiotic treatment within 7 days before sampling. ETEC was recovered in 9 out of 85 (10.6%) children with diarrhea. From these positive cases, 6 were associated with heat-stable (ST), 1 with heat-labile (LT) and 2 with both LT and ST enterotoxins. Only one case (2.6%) of LT-producing ETEC was detected in the control group. In 5 out of 9 ETEC diarrhea cases (55.5%) the isolated strains expressed human colonization factor antigens (CFA); four of them were CFA/I and one CFA/II. The characteristics of the CFA, biotype, serotype and antibiotic sensitivity pattern were studied in 23 E. coli isolates from 10 ETEC positive children. Of the 12 ST only strains, 5 (41.7%) expressed CFA/I and 2 (16.7%) CFA/II (CS2 + CS3). One out of 2 LT/ST strains expressed CFA/I. CFAs were not detected in the ETEC-LT nor in the toxin negative E. coli strains. From the ETEC isolated, 82.4% were resistant to 4 or more antibiotics, whereas only 50% of simultaneously isolated toxin-negative E. coli presented this sensitivity pattern. The different ETEC strains belonged to several different serotypes, some of them rarely observed in other countries. None of these serotypes correlated either with the toxin profile or with the sugar fermentation pattern.(ABSTRACT TRUNCATED AT 250 WORDS)
Binsztein
N
N
Instituto Nacional de Microbiología Carlos G. Malbran, Buenos Aires, Argentina.
Rivas
M
M
López Moral
L
L
Viboud
G
G
Iriarte
C
C
Szefner
M
M
Svennerholm
A M
AM
D001118:Argentina; D001426:Bacterial Proteins / Q000032:analysis; D002675:Child, Preschool; D003968:Diarrhea, Infantile / Q000382:microbiology*; D004352:Drug Resistance, Microbial; D004768:Enterotoxins / Q000096:biosynthesis; D004926:Escherichia coli / Q000187:drug effects / Q000276:immunology / Q000302:isolation & purification; D004927:Escherichia coli Infections / Q000150:complications*; D036781:Fimbriae Proteins; D006801:Humans; D007223:Infant; D007231:Infant, Newborn
D001426:Bacterial Proteins; D004768:Enterotoxins; C022924:colonization factor antigens; D036781:Fimbriae Proteins